{"id":"CVE-2017-17678","aliases":["EUVD-2017-8835","GHSA-w2cx-4cp9-hmm4"],"status":"published","title":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site...","description":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.","severity":{"version":"3.1","score":6.1,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N","level":"medium","assessor":"primary","from":"nvd"},"epss":{"day":"2026-11-08","score":0.00591,"percentile":0.48532,"model":"v2026.06.15"},"facts":{"in_kev":false,"known_exploited":false,"public_exploit":false,"fix_available":false},"cwes":["CWE-79"],"published":"2021-05-19T13:11:01Z","modified":"2026-07-09T00:16:49Z","products":[{"vendor":"bmc","product":"remedy_mid-tier"}],"references":[{"url":"https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html","tags":["x_refsource_MISC","x_transferred","Release Notes","Vendor Advisory"]},{"url":"https://seclists.org/fulldisclosure/2017/Oct/52","tags":["x_refsource_MISC","x_transferred","Mailing List","Third Party Advisory"]},{"url":"https://nvd.nist.gov/vuln/detail/CVE-2017-17678"},{"url":"http://bmc.com"},{"url":"http://remedy.com"},{"url":"https://github.com/advisories/GHSA-w2cx-4cp9-hmm4"}],"sources":{"cve":[{"id":"CVE-2017-17678","description":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.","status":"published","published":"2021-05-19T13:11:01Z","modified":"2026-07-09T00:09:21.122Z","updated_at":"2026-11-02T14:33:18.556155Z"}],"euvd":[{"id":"EUVD-2017-8835","description":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.","status":"published","published":"2021-05-19T13:11:01Z","modified":"2026-07-09T00:09:21Z","updated_at":"2026-11-02T18:20:10.095263Z"}],"ghsa":[{"id":"GHSA-w2cx-4cp9-hmm4","title":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site...","description":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.","status":"published","published":"2022-05-24T19:02:48Z","modified":"2026-07-05T03:31:44Z","cvss":[{"version":"3.1","score":6.1,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N","level":"medium"}],"cwes":["CWE-79"],"updated_at":"2026-11-02T15:09:15.466495Z"}],"nvd":[{"id":"CVE-2017-17678","description":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.","status":"published","published":"2021-05-19T14:15:07.367Z","modified":"2026-07-09T00:16:49.917Z","cvss":[{"version":"3.1","score":6.1,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N","level":"medium","assessor":"primary"},{"version":"2.0","score":4.3,"vector":"AV:N/AC:M/Au:N/C:N/I:P/A:N","level":"medium","assessor":"primary"}],"cwes":["CWE-79"],"updated_at":"2026-11-02T14:04:21.160774Z"}]}}